{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/406798807"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "SUMMARY OF INVENTION [0022] The present invention in its several disclosed embodiments alleviates the drawbacks described above with respect to existing adverse event databases and incorporates several additionally beneficial features. [0023] In a preferred embodiment, the present invention is a method for developing a pharmacovigilance database from source data and reference data." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "google.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/256259394"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/406798807" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/137300572"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/406798807"] } } }
